These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28903171)

  • 1. [Intraabdominal infections].
    Adámková V
    Klin Mikrobiol Infekc Lek; 2017 Jun; 23(2):64-75. PubMed ID: 28903171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-abdominal infections: model of antibiotic stewardship in an era with limited antimicrobial options.
    Leone S; Stefani S; Venditti M; Grossi P; Colizza S; De Gasperi A; Scaglione F; Sganga G; Esposito S;
    Int J Antimicrob Agents; 2011 Sep; 38(3):271-2. PubMed ID: 21782394
    [No Abstract]   [Full Text] [Related]  

  • 3. Current strategies for the treatment of complicated intraabdominal infections.
    Skrupky LP; Tellor BR; Mazuski JE
    Expert Opin Pharmacother; 2013 Oct; 14(14):1933-47. PubMed ID: 23876130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sixty-two-year-old woman with fever and abdominal pain: what antibiotics do I use?
    McCollum DL; Rodriguez JM
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):240-3. PubMed ID: 22020061
    [No Abstract]   [Full Text] [Related]  

  • 5. New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance.
    Syue LS; Chen YH; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2016 Apr; 47(4):250-8. PubMed ID: 27005457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eravacycline for the treatment of patients with bacterial infections.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2018 Apr; 54(4):245-254. PubMed ID: 29869646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections.
    Labricciosa FM; Sartelli M; Abbo LM; Barbadoro P; Ansaloni L; Coccolini F; Catena F
    Surg Infect (Larchmt); 2018 Apr; 19(3):264-272. PubMed ID: 29298133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sparing anti-pseudomonas antibiotics in intraabdominal infections.
    Papagheorghe R; Angelescu N
    Chirurgia (Bucur); 2012; 107(4):488-93. PubMed ID: 23025116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eravacycline (Xerava)--an IV tetracycline for complicated intra-abdominal infections.
    Med Lett Drugs Ther; 2019 Apr; 61(1570):61-63. PubMed ID: 31169809
    [No Abstract]   [Full Text] [Related]  

  • 10. Empiric antibiotic therapy for intraabdominal infections.
    Nichols RL
    Rev Infect Dis; 1983; 5 Suppl 1():S90-7. PubMed ID: 6342104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraabdominal infections in the intensive care unit.
    Friedrich AK; Cahan M
    J Intensive Care Med; 2014; 29(5):247-54. PubMed ID: 23753232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of patients with community-acquired complicated intra-abdominal infections: a prospective, multicentre, observational study.
    Jean SS; Ko WC; Xie Y; Pawar V; Zhang D; Prajapati G; Mendoza M; Kiratisin P; Ramalheira E; Castro AP; Rosso F; Hsueh PR
    Int J Antimicrob Agents; 2014 Sep; 44(3):222-8. PubMed ID: 25106073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A spotlight on the treatment of intraabdominal infections.
    Montravers P; Yung S; Tran-Dinh A
    Expert Rev Clin Pharmacol; 2020 May; 13(5):469-472. PubMed ID: 32511038
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness and Safety of Tigecycline Compared with Other Broad-Spectrum Antimicrobials in Abdominal Solid Organ Transplant Recipients with Polymicrobial Intraabdominal Infections.
    Liebenstein T; Schulz LT; Viesselmann C; Bingen E; Musuuza J; Safdar N; Rose WE
    Pharmacotherapy; 2017 Feb; 37(2):151-158. PubMed ID: 27983753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What every intensivist should know about the management of peritonitis in the intensive care unit.
    Waele JJ
    Rev Bras Ter Intensiva; 2018 Mar; 30(1):9-14. PubMed ID: 29742214
    [No Abstract]   [Full Text] [Related]  

  • 16. ACP Journal Club. After source control in intraabdominal infections, 4-day and longer-duration antibiotics did not differ at 30-days.
    Kadri S; O'Grady NP
    Ann Intern Med; 2015 Oct; 163(8):JC6. PubMed ID: 26502143
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibacterial therapy of severe intra-abdominal infections].
    Boĭko VV; Ivanova IuV
    Klin Khir; 2011 Sep; (9):43-6. PubMed ID: 22168024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Source Identification and Source Control.
    Oliver ZP; Perkins J
    Emerg Med Clin North Am; 2017 Feb; 35(1):43-58. PubMed ID: 27908337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial of short-course antimicrobial therapy for intraabdominal infection.
    Sawyer RG; Claridge JA; Nathens AB; Rotstein OD; Duane TM; Evans HL; Cook CH; O'Neill PJ; Mazuski JE; Askari R; Wilson MA; Napolitano LM; Namias N; Miller PR; Dellinger EP; Watson CM; Coimbra R; Dent DL; Lowry SF; Cocanour CS; West MA; Banton KL; Cheadle WG; Lipsett PA; Guidry CA; Popovsky K;
    N Engl J Med; 2015 May; 372(21):1996-2005. PubMed ID: 25992746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies.
    Heizmann WR; Dupont H; Montravers P; Guirao X; Eckmann C; Bassetti M; García MS; Capparella MR; Simoneau D; Bodmann KF
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii45-55. PubMed ID: 23772046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.